MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

08 Nov 2021 Evaluate
A decrease of about -36.61% in the sales to Rs. 28831.80 millions was observed for the quarter ended September 2021. The sales stood at Rs. 45485.00 millions during the similar quarter previous year.A big loss of -75.19% reported for the quarter ended September 2021 to Rs. 1976.80  millions from Rs. 7969.30 millions.Operating profit for the quarter ended September 2021 decreased to 4221.00 millions as compared to 12506.90 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 28831.80 45485.00 -36.61 57769.30 79744.90 -27.56 158236.80 133707.70 18.35
Other Income 823.70 431.70 90.80 1263.20 1641.30 -23.04 5898.60 2434.30 142.31
PBIDT 4221.00 12506.90 -66.25 8768.60 23321.50 -62.40 47096.80 29412.90 60.12
Interest 34.40 64.50 -46.67 85.00 168.90 -49.67 286.80 979.10 -70.71
PBDT 4186.60 12442.40 -66.35 8683.60 23152.60 -62.49 46810.00 28433.80 64.63
Depreciation 981.80 1212.50 -19.03 2128.30 2417.10 -11.95 4879.90 4733.30 3.10
PBT 3204.80 11229.90 -71.46 6555.30 20735.50 -68.39 41930.10 23700.50 76.92
TAX 1228.00 3260.60 -62.34 2427.80 5690.90 -57.34 10801.00 4931.70 119.01
Deferred Tax 7.60 51.90 -85.36 -227.00 31.20 -827.56 367.60 8.80 4077.27
PAT 1976.80 7969.30 -75.19 4127.50 15044.60 -72.56 31129.10 18768.80 65.86
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 14.64 27.50 -46.76 15.18 29.25 -48.10 29.76 22.00 35.30
Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..